Q4 2019
Released Feb 20, 2020, after the close
10-K filed Feb 20, 2020, 51 days after period end · 0001237831-20-000010
Q4 2019 · 10-K
Revenue$211.67M$211.67M +8.0% vs Q4 2018+8.8% vs Q2 2019
Net Income$45.53M$45.53M +23.9% vs Q4 2018+19.3% vs Q2 2019
EPS Diluted$0.44$0.44 +22.2% vs Q4 2018+15.8% vs Q2 2019
Gross Profit$162,907,000+8.6%
Operating Incomederived$49,980,000+15.6%
Operating Cash Flowderived$54,309,000—
Free Cash Flowderived$38,516,000—
Margins · derived
Gross margin77.0%+0.4 pt vs Q4 2018
Operating margin23.6%+1.5 pt vs Q4 2018
Net margin21.5%+2.8 pt vs Q4 2018
What the release said
The release
Same quarter
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Revenue | $211.67M | $195.94M | $176.03M | $151.59M |
| Net Income | $45.53M | $36.75M | $24.38M | $24.30M |
| EPS Diluted | $0.44 | $0.36 | $0.25 | $0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR